Women want ‘pink viagra’ to make sex better, not more frequent – Broadly

untitled-article-1487219815

Published by Broadly VICE AU, February 17, 2017

by Rebecca Kamm and Sammi Taylor

There were high hopes the arrival of “pink Viagra” would herald a blissful new age of pharmaceutically enhanced female libidos. But the uptake of flibanserin, approved by the FDA in 2015 for the treatment of low sex drive in women (also known as hypoactive sexual desire disorder), has failed to sparked the revolution it might have. The effects of the drug, which is currently being sold under the trade name Addyi, are reportedly small: somewhere between eight and 13 percent. Secondly, its potential side effects include nausea, sleepiness, and dizziness—decidedly unsexy states of being for most of us.

Read the story online.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s